{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T15:48:52Z","timestamp":1767973732704,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.urology.2018.10.004","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T17:59:02Z","timestamp":1539194342000},"page":"93-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["MicroRNA Expression Profiles in Upper Tract Urothelial Carcinoma Differentiate Tumor Grade, Stage, and Survival: Implications for Clinical Decision-Making"],"prefix":"10.1016","volume":"123","author":[{"given":"Brendan M.","family":"Browne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristian D.","family":"Stensland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chintan K.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Travis","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric J.","family":"Burks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Canes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay D.","family":"Raman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Warrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly M.","family":"Reiger-Christ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2018.10.004_bib0001","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","article-title":"European Association of Urology Guidelines on upper urinary tract urothelial carcinoma: 2017 update","volume":"73","author":"Roupr\u00eat","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2018.10.004_bib0002","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.eururo.2016.07.014","article-title":"Oncologic outcomes of kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the EAU non-muscle invasive bladder cancer guidelines panel","volume":"70","author":"Seisen","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2018.10.004_bib0003","doi-asserted-by":"crossref","first-page":"e743","DOI":"10.1016\/j.clgc.2018.01.015","article-title":"An analysis of staging and treatment trends for upper tract urothelial carcinoma in the National Cancer Database","volume":"16","author":"Browne","year":"2018","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urology.2018.10.004_bib0004","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2012.02.030","article-title":"Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature","volume":"62","author":"Lughezzani","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2018.10.004_bib0005","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.eururo.2014.03.003","article-title":"A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma","volume":"66","author":"Leow","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2018.10.004_bib0006","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/cncr.24135","article-title":"Outcomes of radical nephroureterectomy: a series from the UPPER TRACT UROTHELIAL CARCINOMA COLlaboration","volume":"115","author":"Margulis","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2018.10.004_bib0007","doi-asserted-by":"crossref","first-page":"6188","DOI":"10.1038\/sj.onc.1209913","article-title":"A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes","volume":"25","author":"Kent","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.urology.2018.10.004_bib0008","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/bju.13886","article-title":"Profiling microRNA from nephrectomy and biopsy specimens: predictors of progression and survival in clear cell renal cell carcinoma","volume":"120","author":"Kowalik","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2018.10.004_bib0009","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1007\/s00018-016-2176-3","article-title":"Dissecting the role of microRNAs in prostate cancer metastasis: implications for the design of novel therapeutic approaches","volume":"73","author":"Doldi","year":"2016","journal-title":"Cell Mol Life Sci."},{"key":"10.1016\/j.urology.2018.10.004_bib0010","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000444493","article-title":"miRNA-503 promotes tumor progression and is associated with early recurrence and poor prognosis in human colorectal cancer","volume":"90","author":"Noguchi","year":"2016","journal-title":"Oncology"},{"key":"10.1016\/j.urology.2018.10.004_bib0011","doi-asserted-by":"crossref","first-page":"121","DOI":"10.7754\/Clin.Lab.2015.150607","article-title":"Abnormal miRNA-30e expression is associated with breast cancer progression","volume":"62","author":"Lin","year":"2016","journal-title":"Clin Lab"},{"key":"10.1016\/j.urology.2018.10.004_bib0012","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.urolonc.2009.08.024","article-title":"A MicroRNA expression profile defining the invasive bladder tumor phenotype","volume":"29","author":"Wszolek","year":"2011","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2018.10.004_bib0013","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/bju.12551","article-title":"Prognostic value of microRNA expression pattern in upper tract urothelial carcinoma","volume":"113","author":"Izquierdo","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2018.10.004_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117284","article-title":"Analysis of tissue and serum microRNA expression in patients with upper urinary tract urothelial cancer","volume":"10","author":"Kriebel","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.urology.2018.10.004_bib0015","doi-asserted-by":"crossref","first-page":"e1826","DOI":"10.3390\/ijms18081826","article-title":"MiR-30a-5p inhibits epithelial-to-mesenchymal transition and upregulates expression of tight junction protein Claudin-5 in human upper tract urothelial carcinoma cells","volume":"18","author":"Chung","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.urology.2018.10.004_bib0016","doi-asserted-by":"crossref","first-page":"e91646","DOI":"10.1371\/journal.pone.0091646","article-title":"New miRNA profiles accurately distinguish renal cell carcinomas and upper tract urothelial carcinomas from the normal kidney","volume":"9","author":"Zaravinos","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.urology.2018.10.004_bib0017","doi-asserted-by":"crossref","first-page":"51522","DOI":"10.18632\/oncotarget.17884","article-title":"Prognostic microRNAs in upper tract urothelial carcinoma: multicenter and international validation study","volume":"8","author":"Izquierdo","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.urology.2018.10.004_bib0018","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene expression omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.urology.2018.10.004_bib0019","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1464-410X.2008.07659.x","article-title":"Molecular and histological markers in urothelial carcinomas of the upper urinary tract","volume":"102","author":"Eltz","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2018.10.004_bib0020","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12943-015-0466-2","article-title":"MicroRNA molecular profiling from matched tumor and bio-fluids in bladder cancer","volume":"14","author":"Armstrong","year":"2015","journal-title":"Mol Cancer"},{"key":"10.1016\/j.urology.2018.10.004_bib0021","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.urolonc.2013.11.001","article-title":"The role of microRNA profiling in prognosticating progression in Ta and T1 urinary bladder cancer","volume":"32","author":"Segersten","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2018.10.004_bib0022","doi-asserted-by":"crossref","first-page":"e88057","DOI":"10.1371\/journal.pone.0088057","article-title":"MicroRNA-10a is down-regulated by DNA methylation and functions as a tumor suppressor in gastric cancer cells","volume":"9","author":"Jia","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.urology.2018.10.004_bib0023","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.3892\/etm.2017.4685","article-title":"MicroRNA differential expression spectrum and microRNA-125a-5p inhibition of laryngeal cancer cell proliferation","volume":"14","author":"Yao","year":"2017","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.urology.2018.10.004_bib0024","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1111\/cas.13331","article-title":"Regulation of spindle and kinetochore-associated protein 1 by antitumor miR-10a-5p in renal cell carcinoma","volume":"108","author":"Arai","year":"2017","journal-title":"Cancer Sci"},{"key":"10.1016\/j.urology.2018.10.004_bib0025","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1007\/s11033-014-3132-7","article-title":"MicroRNA-30c serves as an independent biochemical recurrence predictor and potential tumor suppressor for prostate cancer","volume":"41","author":"Ling","year":"2014","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.urology.2018.10.004_bib0026","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1159\/000460618","article-title":"A feedback loop between miR-30a\/c-5p and DNMT1 mediates cisplatin resistance in ovarian cancer cells","volume":"41","author":"Han","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.urology.2018.10.004_bib0027","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1038\/onc.2010.169","article-title":"Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas","volume":"29","author":"Braun","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.urology.2018.10.004_bib0028","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/ijc.30790","article-title":"Plasma microRNAs as biomarkers of pancreatic cancer risk in a prospective cohort study","volume":"141","author":"Duell","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urology.2018.10.004_bib0029","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"Volinia","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.urology.2018.10.004_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2013.06.015","article-title":"High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy","volume":"32","author":"Raman","year":"2014","journal-title":"Urol Oncol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429518310860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429518310860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T04:01:06Z","timestamp":1570507266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429518310860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":30,"alternative-id":["S0090429518310860"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2018.10.004","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA Expression Profiles in Upper Tract Urothelial Carcinoma Differentiate Tumor Grade, Stage, and Survival: Implications for Clinical Decision-Making","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2018.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}